| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |